Paracetamol syrup sales suspended in Gambia over death of dozens of young children
The children suffered symptoms including an inability to pass urine, fever and vomiting that quickly led to kidney failure.
Banjul: Gambia on Tuesday ordered importers and shops to suspend sales of all brands of paracetamol syrup while the government investigates a suspected link between the medicine and the deaths of dozens of young children.
Last Thursday, the head of the West African country's health service said it had launched the probe after a spike in cases of acute kidney injury among children under the age of five was detected in late July.
The medicines regulator, known as the Medicines Control Agency (MCA), said there was insufficient data to warrant a general ban on paracetamol syrups, a painkiller often used to treat fevers in children.
The children suffered symptoms including an inability to pass urine, fever and vomiting that quickly led to kidney failure.
It did not name any specific brands, but said some samples had been sent abroad for quality control testing.
Last week, World Health Organisation officials said the evidence pointed not to paracetamol but to an infectious origin such as polluted water, but emphasised there were many unanswered questions
Read also: Gambia probes suspected paracetamol syrup link to dozens of child deaths
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.